Russell Giambelluca Named Assistant Vice President for Finance, Financial Planning, and Services

Troy, N.Y. - Russell Giambelluca has been named assistant vice president for finance, financial planning, and services at Rensselaer Polytechnic Institute. Giambelluca assumes his position on Oct. 1. Among Giambelluca's responsibilities will be developing annual operating and capital budgets, and budget forecasts. He will be enhancing Institutewide financial and budgetary standards and procedures. He also will train and oversee Rensselaer's financial, business, and budget personnel.

Rensselaer's Lally School Names the 2003 Recipient of the Herman Family Fellowship

Troy, N.Y. - Rensselaer Polytechnic Institute's Lally School of Management and Technology has awarded incoming MBA student Azmat Ahmad its prestigious Herman Family Fellowship for Women in Entrepreneurship. The prize supports up to two females enrolled in the Lally School's MBA program each year, and helps them pursue their entrepreneurial interests.

Anthrax Research Might Provide More Time for Treatment

Troy, N.Y. - Researchers at Rensselaer Polytechnic Institute in Troy, N.Y., have been awarded new federal grant money to develop experimental compounds that may someday extend the period during which a person exposed to anthrax can be treated successfully. Ravi Kane, assistant professor of chemical and biological engineering at Rensselaer, has been awarded a grant of $500,000 from the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to develop inhibitors of the anthrax toxin.

Early Infection and Rejection Detection: Microdialysis Technique May Help Implants Stay Put Longer

Troy, N.Y. - Julie Stenken, associate professor of analytical chemistry at Rensselaer Polytechnic Institute in Troy, N.Y., has received a four-year, $750,000 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a new technique that can be used to study the body's reaction to medical implants at the cellular level. Millions of medical devices, including catheters, pacemakers, vascular grafts, and glucose sensors, are regularly implanted into humans.

Back to top